Ariana Pharma strengthens SAB with appointment of world-leading Neurologist
Cambridge, MA, USA and Paris, France, March 27, 2023 – Ariana Pharma, the leading Al-driven precision medicine company, has announced the appointment of Professor Jacques Touchon to its Scientific Advisory Board. Ariana is pleased to announce that Professor Jacques Touchon, a world-renowned neurologist, Alzheimer’s Disease specialist, and co-founder of the Clinical Trials on Alzheimer’s Disease (CTAD) international convention has joined its scientific advisory board.
Professor Touchon will help bolster Ariana Pharma’s clinical expertise in the field of CNS diseases and expand the company’s collaborations internationally. He will be joining the Ariana SAB Professor Jean Sallantin, a pioneer of French bioinformatics and former Director of the Artificial Intelligence Laboratories at the LIRMM CNRS, and Dr. Alain Commerçon, former Senior Research Director within the Lead Generation organization at Sanofi-Aventis. En savoir plus
